[Form 4] Albemarle Corporation Insider Trading Activity

Rhea-AI Filing Summary

Albemarle Corporation (ALB) – Form 4 insider filing dated 07/03/2025

Non-employee director Alejandro Daniel Wolff reported two routine equity transactions carried out under the company’s 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors:

• Common stock dividend equivalents: 37 shares were credited on 07/01/2025 as dividend equivalents on a prior equity award that vested the same day. These shares were acquired at $0 cost, bringing the director’s directly held common stock to 12,539 shares.
• Phantom stock grant: 2,725 phantom stock units (1-for-1 convertible into common shares) were awarded on 07/01/2025. The units vest on 07/01/2026 and have no stated expiration date. Including this grant and associated dividend equivalents, the director now holds 6,278 phantom stock units.

No sales or dispositions were reported. The transactions were made at $0 price and do not involve open-market purchases or sales. As Wolff remains on the board, these grants represent standard annual director compensation and dividend accruals rather than signal-bearing insider buying or selling.

Overall, the filing reflects normal course equity accrual that slightly increases insider alignment but is immaterial to Albemarle’s share count or valuation. There is no indication of strategic intent or upcoming corporate events.

Positive

• Increased insider ownership – Director’s direct common stock holdings rose to 12,539 shares, marginally improving board-shareholder alignment.

Negative

• None.

Insights

Equity Compensation Analyst

TL;DR – Routine director stock and phantom unit accrual; negligible market impact.

The 37 dividend shares and 2,725 phantom units stem from Albemarle’s pre-disclosed 2023 Directors Plan. Both are non-cash, $0-priced issuances that increase Mr. Wolff’s beneficial ownership but represent less than 0.01% of ALB’s ~117 million outstanding shares. Such awards are customary among S&P 500 boards and do not convey insider sentiment. The lack of dispositions suggests continued board alignment, yet the scale is too small to influence float or valuation. Investors typically disregard these entries unless they reveal material accumulation or liquidation, which is not the case here.

Portfolio Manager

TL;DR – Neutral filing; no buy/sell signal for ALB.

Insider filings can foreshadow sentiment, but this Form 4 is a textbook administrative disclosure. No market purchases were made, and the phantom stock grant is preset compensation. The director’s total direct stake (~$1.5 m at $120/sh) remains modest relative to board peers. I see no incremental information to adjust position sizing or risk models. The filing is not impactful for trading decisions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wolff Alejandro Daniel

(Last) (First) (Middle)

ALBEMARLE CORPORATION

4250 CONGRESS STREET, SUITE 900

(Street)

CHARLOTTE NC 28209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		A		37(1)	A	$0	12,539	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock	(2)	07/01/2025		A		2,725(3)		(4)	(5)	Common Stock	2,725	$0	6,278(6)	D

Explanation of Responses:

1. Represents dividends accrued on shares underlying an award granted on July 1, 2024, that vested in full on July 1, 2025, which the Issuer elected to settle in shares of common stock under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan").

2. Phantom Stock units convert 1 for 1 into common stock.

3. Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Directors Plan. Shares to vest on July 1, 2026.

4. Payable as shares of common stock upon events established by the reporting person in accordance with the terms of the 2023 Directors Plan.

5. No expiration date.

6. Includes dividend equivalent rights earned based on total Phantom Stock units in Director's deferred stock account.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Rebekah Richards, Attorney-in-Fact	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Albemarle (ALB) disclose in the July 2025 Form 4?

Director Alejandro Wolff acquired 37 dividend shares and 2,725 phantom stock units as part of routine board compensation.

Did the Albemarle director sell any shares?

No sales or dispositions were reported; all transactions were acquisitions at $0 price.

How many Albemarle shares does the director now own?

After the transactions, Wolff holds 12,539 common shares directly and 6,278 phantom stock units.

When will the 2,725 phantom stock units vest?

The phantom units are scheduled to vest on July 1, 2026.

Is the Form 4 filing material to Albemarle investors?

The amounts are immaterial (<0.01% of shares outstanding) and are considered routine director compensation.